JP2023505233A5 - - Google Patents
Info
- Publication number
- JP2023505233A5 JP2023505233A5 JP2022533468A JP2022533468A JP2023505233A5 JP 2023505233 A5 JP2023505233 A5 JP 2023505233A5 JP 2022533468 A JP2022533468 A JP 2022533468A JP 2022533468 A JP2022533468 A JP 2022533468A JP 2023505233 A5 JP2023505233 A5 JP 2023505233A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- dosage form
- unit dosage
- active agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944258P | 2019-12-05 | 2019-12-05 | |
| US62/944,258 | 2019-12-05 | ||
| US202063074770P | 2020-09-04 | 2020-09-04 | |
| US63/074,770 | 2020-09-04 | ||
| PCT/US2020/063307 WO2021113635A1 (en) | 2019-12-05 | 2020-12-04 | Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505233A JP2023505233A (ja) | 2023-02-08 |
| JP2023505233A5 true JP2023505233A5 (enExample) | 2023-12-11 |
Family
ID=76221221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533468A Pending JP2023505233A (ja) | 2019-12-05 | 2020-12-04 | アシル化された活性薬剤並びに代謝異常及び非アルコール性脂肪性肝疾患の治療のためのそれらの使用の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220296555A1 (enExample) |
| EP (1) | EP4069208A4 (enExample) |
| JP (1) | JP2023505233A (enExample) |
| AU (1) | AU2020397933A1 (enExample) |
| CA (1) | CA3163526A1 (enExample) |
| WO (1) | WO2021113635A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3205899B2 (ja) * | 1997-07-18 | 2001-09-04 | 株式会社浅井ゲルマニウム研究所 | 糖尿病又は腎不全に伴う合併症の診断試薬 |
| CA2344053C (en) * | 1998-09-15 | 2007-04-03 | Korea Research Institute Of Bioscience And Biotechnology | Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| JP2000256259A (ja) * | 1999-03-11 | 2000-09-19 | Nippon Zoki Pharmaceut Co Ltd | メイラード反応阻害剤 |
| PL1771191T3 (pl) * | 2004-07-19 | 2014-08-29 | Nutricia Nv | Preparat do zastosowania asparaginianu i witaminy B12 lub biotyny do regulowania poziomu ciał ketonowych |
| CN101167802B (zh) * | 2006-10-25 | 2011-04-20 | 中国科学院上海生命科学研究院 | 肉桂提取物的制备方法、肉桂提取物、其组合物以及用途 |
| JP5213961B2 (ja) * | 2008-09-18 | 2013-06-19 | 日本臓器製薬株式会社 | アミノ酸誘導体 |
| JP2016216378A (ja) * | 2015-05-15 | 2016-12-22 | 公立大学法人岡山県立大学 | ウロリチン類を含有する抗糖化剤 |
| JP2017171638A (ja) * | 2016-03-25 | 2017-09-28 | 花王株式会社 | 骨強度改善剤 |
-
2020
- 2020-12-04 AU AU2020397933A patent/AU2020397933A1/en not_active Abandoned
- 2020-12-04 JP JP2022533468A patent/JP2023505233A/ja active Pending
- 2020-12-04 CA CA3163526A patent/CA3163526A1/en active Pending
- 2020-12-04 EP EP20897383.4A patent/EP4069208A4/en not_active Withdrawn
- 2020-12-04 WO PCT/US2020/063307 patent/WO2021113635A1/en not_active Ceased
-
2022
- 2022-06-03 US US17/831,562 patent/US20220296555A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103338762B (zh) | 血糖值上升抑制剂 | |
| JP2021528384A5 (enExample) | ||
| EP3723511A1 (en) | Compositions and methods for weight loss maintenance | |
| KR20080106455A (ko) | 대사장애의 조합치료 | |
| WO2020009111A1 (ja) | 脂肪蓄積抑制用組成物 | |
| JP2022524962A (ja) | 中鎖トリグリセリドの食前投与により食事に由来する食後血糖を低減する方法 | |
| WO2007049818A1 (ja) | 抗脂肪肝、抗肥満及び抗高脂血症用組成物 | |
| JPWO2007114499A1 (ja) | 抗脂肪蓄積用組成物 | |
| CN112955132A (zh) | 用于预防或治疗肥胖或非酒精性脂肪性肝炎的包含氢醌衍生物的药物组合物 | |
| WO2022230920A1 (ja) | 血中カルニチン増加剤 | |
| JP2023504547A5 (enExample) | ||
| HK1257401A1 (zh) | 用於治疗糖尿病和相关病症的方法和组合物 | |
| JP4139544B2 (ja) | 血糖値低下剤 | |
| WO2018102914A1 (en) | Use of medium-chain triglycerides for the management of metabolic conditions | |
| AU2021336289A2 (en) | Ionic liquid formulations for treating diabetes | |
| CN1452482A (zh) | 含有胆碱和琥珀酸用于治疗胰岛素抵抗和糖尿病的协同组成物 | |
| JP3029907B2 (ja) | 抗肥満剤 | |
| JP2001240544A (ja) | 抗肥満剤及び脂質代謝改善剤 | |
| EP2730281A1 (en) | Anti-obesity agent comprising high-purity epa | |
| WO2000051594A1 (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
| JPWO2007069744A1 (ja) | メタボリックシンドローム予防・改善用組成物 | |
| CN1477974A (zh) | 抗肥胖剂和健康食品 | |
| EP1219297A1 (en) | Antiobestic agents | |
| US20250235415A1 (en) | Modulation of human breast milk composition | |
| US20240423941A1 (en) | Medium chain dicarboxylic acids for the treatment and prevention of diseases and conditions |